
UC Davis Clinical Trial Shows Biomarkers May Hold Clue in Treating Aggressive Prostate Cancer | Newswise
Newswise — Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical trial at UC Davis Comprehensive Cancer Center unveiled clues as to why these patients are doing poorly and may offer hope in the form of targeted therapy. The findings will be presented at…